SEC Filings
| Filing date | Description | Form | Filing Group | Issuer | View |
|---|---|---|---|---|---|
| View HTML | Statement of changes in beneficial ownership of securities |
4 |
3,4,5
|
Eidos Therapeutics, Inc. | |
| View HTML | Report of unscheduled material events or corporate event |
8-K |
Current Reports
|
Eidos Therapeutics, Inc. | |
| View HTML | Initial filing by director officer or owner of more than ten percent. |
3 |
3,4,5
|
Eidos Therapeutics, Inc. | |
| View HTML | Statement of changes in beneficial ownership of securities |
4 |
3,4,5
|
Eidos Therapeutics, Inc. | |
| View HTML | Statement of changes in beneficial ownership of securities |
4 |
3,4,5
|
Eidos Therapeutics, Inc. | |
| View HTML | Statement of changes in beneficial ownership of securities |
4 |
3,4,5
|
Eidos Therapeutics, Inc. | |
| View HTML EX-101.INS - XBRL INSTANCE DOCUMENT | Quarterly report which provides a continuing view of a company's financial position |
10-Q |
Quarterly Filings
|
Eidos Therapeutics, Inc. | |
| View HTML | Report of unscheduled material events or corporate event |
8-K |
Current Reports
|
Eidos Therapeutics, Inc. | |
| View HTML | Report of unscheduled material events or corporate event |
8-K |
Current Reports
|
Eidos Therapeutics, Inc. | |
| View HTML EX-101.INS - XBRL INSTANCE DOCUMENT | Quarterly report which provides a continuing view of a company's financial position |
10-Q |
Quarterly Filings
|
Eidos Therapeutics, Inc. |
Displaying 11 - 20 of 51 results
Copyright Morningstar